Australia markets closed

IQVIA Holdings Inc. (0JDM.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
215.24+0.60 (+0.28%)
At close: 07:14PM GMT

IQVIA Holdings Inc.

2400 Ellis Road
Durham, NC 27703
United States
919 998 2000

Full-time employees87,000

Key executives

NameTitlePayExercisedYear born
Mr. Ari BousbibChairman, President & CEO8.33MN/A1961
Mr. Ronald E. BruehlmanExecutive VP & CFO2.38MN/A1961
Mr. Eric M. SherbetExecutive VP, General Counsel & Secretary1.33MN/A1964
Mr. Kevin C. KnightlyPresident of Corporate Strategy & Enterprise Networks1.32MN/A1961
Ms. Keriann CherofskySenior VP, Corporate Controller & Principal Accounting OfficerN/AN/A1984
Dr. Jeffrey A. SpaederSenior VP, Global Chief Medical & Scientific OfficerN/AN/AN/A
Mr. Karl GuenaultSenior VP & Chief Information OfficerN/AN/AN/A
Mr. Nicholas ChildsSenior Vice President of Investor Relations & TreasuryN/AN/AN/A
Ms. Trudy SteinChief Human Resources Officer & Executive VPN/AN/AN/A
Dr. Cynthia L. VerstPresident of Design & Delivery InnovationN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.

Corporate governance

IQVIA Holdings Inc.’s ISS governance QualityScore as of 1 December 2023 is 8. The pillar scores are Audit: 8; Board: 8; Shareholder rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.